explore -WSS

explore

author：leisure time 2025-10-01 01:51:16 - browse：252

Astrazeneca office building -- health policy coverage from STAT — AstraZeneca is suing the Biden administration to stop a new Medicare drug price negotiation program. Adobe

WASHINGTON — AstraZeneca is the sixth drugmaker to pile on a legal challenge to the Biden administration’s drug pricing reform law.

The Medicare drug price negotiation program created in the Inflation Reduction Act is set to kick off in the next week, as officials will release the names of the first 10 medicines that will be selected for the program. Medicines are eligible for selection if they are one of the highest-spend drugs for Medicare, and they have no generic competition.

AstraZeneca makes drugs that could be selected for the list, and asked a Delaware district court judge to rule that Medicare acted illegally and that the law is unconstitutional.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： How a Boston hospital is priming medical residents to use GPT

WSS

Cancer, immunology, HIV research ensnared in fetal tissue politics

This gene therapy has record $4.25 million price. It's saved children.

'Patient friction coefficient' can gauge a clinical trial's patient burden

Adam's Take: Intra

Bring on the sabbaticals for nurses

Medicare Advantage insurers pressure Biden for bigger payments

Wikipedia

explore

hotspot

The high cost of giving birth even with insurance

Are infertility treatments 'essential' during the Covid

How one medical school became remarkably diverse

Pregnancy ages women, but effects reverse after delivery

Jerome Adams on the need for new antivirals for Covid

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

Supreme Court strikes down use of affirmative action

Medical devices makers are asking for forgiveness, not permission

Affirmative action in medical school literally saved lives

Pfizer, Moderna say biotech, pharma drug development is a sprint

hotspot

Diabetes management: Digital health tools fall short, study says

Testing GLP

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Medicare Advantage insurers pressure Biden for bigger payments

Scientists grapple with ethics of stem cell research

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

leisure time

hotspot

leisure time

hotspot